Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Total revenues	$ 25,429,855	$ 8,323,025
Operating expenses
Cost of sales and supportive services	3,225,314	1,150,187
Selling, general and administrative	7,875,773	4,235,108
Research and development	3,053,369	5,046,036
Total operating expenses	14,154,456	10,431,331
Operating income/(loss)	11,275,399	(2,108,306)
Other income, net	1,942,437	890,629
Income/(Loss) before income taxes	13,217,836	(1,217,677)
(Provision)/Benefit for income taxes	(2,940,496)	299,422
Net and comprehensive income/(loss)	$ 10,277,340	$ (918,255)
Basic income/(loss) per share (in dollars per share)	$ 0.14	$ (0.01)
Diluted income/(loss) per share (in dollars per share)	$ 0.14	$ (0.01)
Weighted average shares outstanding: basic (in shares)	71,093,653	72,197,038
Weighted average shares outstanding: diluted (in shares)	71,562,996	72,197,038
Product Sales and Supportive Services [Member]
Revenues
Total revenues	$ 23,878,677	$ 5,702,515
Research and Development [Member]
Revenues
Total revenues	$ 1,551,178	$ 2,620,510